Missouri SB878 modifies provisions for pharmacists to provide medication therapy services and prescribe certain devices.

Missouri SB878 repeals and replaces existing provisions to allow pharmacists with a certificate of medication therapeutic plan authority to provide medication therapy services for influenza, group A streptococcus, and COVID-19. The bill also allows pharmacists to prescribe durable medical equipment (DME) that meets specific criteria, such as being primarily used for medical purposes and having an expected life of at least three years.

Missouri SB878 modifies provisions for pharmacists to provide medication therapy services and prescribe certain devices.

Missouri SB878 repeals and replaces existing provisions to allow pharmacists with a certificate of medication therapeutic plan authority to provide medication therapy services for influenza, group A streptococcus, and COVID-19. The bill also allows pharmacists to prescribe durable medical equipment (DME) that meets specific criteria, such as being primarily used for medical purposes and having an expected life of at least three years.